C-reactive protein: A poor marker of cardiovascular disease risk in HIV+ populations with a high prevalence of elevated serum transaminases

Marianna K. Baum, C. Rafie, S. Sales, S. Lai, R. Duan, Dushyantha T Jayaweera, John Page, A. Campa

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Blood lipids and high-sensitivity C-reactive protein (hsCRP) are used to assess cardiovascular disease (CVD) risk. We evaluated in a cross-sectional design the relationship of hsCRP to markers of liver function (aspartate and alanine transaminases [AST and ALT, respectively]), CVD risk factors and HIV-disease progression markers in 226 HIV-1 sero-positive drug users. hsCRP showed a significant inverse relationship with ALT and high-density lipoprotein, independent of age, gender, viral load, CD4 cellcount and antiretroviral (ARV) use, and was not significantly associated with HIV-disease progression markers. Serum markers of liver damage, AST and ALT, were associated with lower hsCRP, total cholesterol, low-density lipoproteins and triglycerides. Elevated liver enzymes (≥40 IU/L) were predictive of hsCRP levels that are considered a low risk for CVD. In conclusion, hsCRP may not be a reliable marker of CVD risk in populations with HIV at-risk for elevated liver enzymes due to high hepatitis B virus/hepatitis C virus prevalence and ARV use.

Original languageEnglish
Pages (from-to)410-413
Number of pages4
JournalInternational Journal of STD and AIDS
Volume19
Issue number6
DOIs
StatePublished - Jun 1 2008

Fingerprint

Staphylococcal Protein A
Transaminases
C-Reactive Protein
Cardiovascular Diseases
HIV
Serum
Population
Liver
Disease Progression
Enzymes
HDL Lipoproteins
Aspartate Aminotransferases
Drug Users
Viral Load
Alanine Transaminase
Hepatitis B virus
Hepacivirus
HIV-1
Biomarkers
Cholesterol

Keywords

  • ALT
  • AST
  • C-reactive protein
  • CVD risk
  • HIV-1
  • Liver damage

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Immunology

Cite this

C-reactive protein : A poor marker of cardiovascular disease risk in HIV+ populations with a high prevalence of elevated serum transaminases. / Baum, Marianna K.; Rafie, C.; Sales, S.; Lai, S.; Duan, R.; Jayaweera, Dushyantha T; Page, John; Campa, A.

In: International Journal of STD and AIDS, Vol. 19, No. 6, 01.06.2008, p. 410-413.

Research output: Contribution to journalArticle

@article{50bb2bbfb3cb4ecabf42c6ccc757d2d8,
title = "C-reactive protein: A poor marker of cardiovascular disease risk in HIV+ populations with a high prevalence of elevated serum transaminases",
abstract = "Blood lipids and high-sensitivity C-reactive protein (hsCRP) are used to assess cardiovascular disease (CVD) risk. We evaluated in a cross-sectional design the relationship of hsCRP to markers of liver function (aspartate and alanine transaminases [AST and ALT, respectively]), CVD risk factors and HIV-disease progression markers in 226 HIV-1 sero-positive drug users. hsCRP showed a significant inverse relationship with ALT and high-density lipoprotein, independent of age, gender, viral load, CD4 cellcount and antiretroviral (ARV) use, and was not significantly associated with HIV-disease progression markers. Serum markers of liver damage, AST and ALT, were associated with lower hsCRP, total cholesterol, low-density lipoproteins and triglycerides. Elevated liver enzymes (≥40 IU/L) were predictive of hsCRP levels that are considered a low risk for CVD. In conclusion, hsCRP may not be a reliable marker of CVD risk in populations with HIV at-risk for elevated liver enzymes due to high hepatitis B virus/hepatitis C virus prevalence and ARV use.",
keywords = "ALT, AST, C-reactive protein, CVD risk, HIV-1, Liver damage",
author = "Baum, {Marianna K.} and C. Rafie and S. Sales and S. Lai and R. Duan and Jayaweera, {Dushyantha T} and John Page and A. Campa",
year = "2008",
month = "6",
day = "1",
doi = "10.1258/ijsa.2007.007207",
language = "English",
volume = "19",
pages = "410--413",
journal = "International Journal of STD and AIDS",
issn = "0956-4624",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - C-reactive protein

T2 - A poor marker of cardiovascular disease risk in HIV+ populations with a high prevalence of elevated serum transaminases

AU - Baum, Marianna K.

AU - Rafie, C.

AU - Sales, S.

AU - Lai, S.

AU - Duan, R.

AU - Jayaweera, Dushyantha T

AU - Page, John

AU - Campa, A.

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Blood lipids and high-sensitivity C-reactive protein (hsCRP) are used to assess cardiovascular disease (CVD) risk. We evaluated in a cross-sectional design the relationship of hsCRP to markers of liver function (aspartate and alanine transaminases [AST and ALT, respectively]), CVD risk factors and HIV-disease progression markers in 226 HIV-1 sero-positive drug users. hsCRP showed a significant inverse relationship with ALT and high-density lipoprotein, independent of age, gender, viral load, CD4 cellcount and antiretroviral (ARV) use, and was not significantly associated with HIV-disease progression markers. Serum markers of liver damage, AST and ALT, were associated with lower hsCRP, total cholesterol, low-density lipoproteins and triglycerides. Elevated liver enzymes (≥40 IU/L) were predictive of hsCRP levels that are considered a low risk for CVD. In conclusion, hsCRP may not be a reliable marker of CVD risk in populations with HIV at-risk for elevated liver enzymes due to high hepatitis B virus/hepatitis C virus prevalence and ARV use.

AB - Blood lipids and high-sensitivity C-reactive protein (hsCRP) are used to assess cardiovascular disease (CVD) risk. We evaluated in a cross-sectional design the relationship of hsCRP to markers of liver function (aspartate and alanine transaminases [AST and ALT, respectively]), CVD risk factors and HIV-disease progression markers in 226 HIV-1 sero-positive drug users. hsCRP showed a significant inverse relationship with ALT and high-density lipoprotein, independent of age, gender, viral load, CD4 cellcount and antiretroviral (ARV) use, and was not significantly associated with HIV-disease progression markers. Serum markers of liver damage, AST and ALT, were associated with lower hsCRP, total cholesterol, low-density lipoproteins and triglycerides. Elevated liver enzymes (≥40 IU/L) were predictive of hsCRP levels that are considered a low risk for CVD. In conclusion, hsCRP may not be a reliable marker of CVD risk in populations with HIV at-risk for elevated liver enzymes due to high hepatitis B virus/hepatitis C virus prevalence and ARV use.

KW - ALT

KW - AST

KW - C-reactive protein

KW - CVD risk

KW - HIV-1

KW - Liver damage

UR - http://www.scopus.com/inward/record.url?scp=47949094134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47949094134&partnerID=8YFLogxK

U2 - 10.1258/ijsa.2007.007207

DO - 10.1258/ijsa.2007.007207

M3 - Article

C2 - 18595880

AN - SCOPUS:47949094134

VL - 19

SP - 410

EP - 413

JO - International Journal of STD and AIDS

JF - International Journal of STD and AIDS

SN - 0956-4624

IS - 6

ER -